[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100267065":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Imperial College London","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Jadwiga Wedzicha","PRINCIPAL_INVESTIGATOR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Jadwiga A Wedzicha, MD","CONTACT","2075947947","j.wedzicha@imperial.ac.uk",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Gavin C Donaldson, PhD","207 4947859","gavin.donaldson@imperial.ac.uk",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"National Heart and Lung Institute, Imperial College","RECRUITING","London","SW3 6LR","United Kingdom","UK",{"type":31,"coordinates":32},"Point",[33,34],-0.12574,51.50853,{"lat":34,"lon":33},[37,39],{"name":19,"role":15,"phone":38,"phoneExt":7,"email":21},"44 (0) 207 594 7859",{"name":14,"role":15,"phone":40,"phoneExt":7,"email":17},"44 (0) 207 594 7947",{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100267065","the-london-copd-exacerbation-cohort-100267065",false,"NCT02755974","The London COPD Exacerbation Cohort","Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.","EXCEL_Cohort","Inclusion Criteria:\n\n* Forced Expiratory Volume in 1 sec (FEV1)\u002FForced Vital Capacity (FVC) ratio of \\\u003C0.70\n* Able and willing to give informed and written consent\n\nExclusion Criteria:\n\n* Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.\n* Patients on Immunosuppressive medications or with active cancer\n* Long term steroid therapy\n* Age \\\u003C40 years at recruitment","ALL","40 Years","100 Years",{"count":55,"type":56},300,"ESTIMATED","OBSERVATIONAL","The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.",[60],"Pulmonary Disease, Chronic Obstructive",[62],"Chronic Obstructive Pulmonary Disease","2022-06-16",{"date":65,"type":66},"2022-06-21","ACTUAL",{"date":68,"type":66},"2009-01",{"date":70,"type":56},"2026-12-31",{"name":5,"class":6},1]